This individual-patient-data meta-analysis compared early routine MCS with standard care in infarct-related cardiogenic shock across nine trials, including 213 women and 845 men. Six-month mortality was higher in women than men (60% versus 52%). MCS did not significantly reduce six-month mortality in women (HR 0.99, 95% CI 0.70–1.42) or men (0.84, 0.70–1.02; interaction P=0.41). In the exploratory DanGer Shock-like subgroup, mortality estimates differed between men (HR 0.66, 95% CI 0.51–0.86) and women (1.18, 0.72–1.91; interaction P=0.02). MCS increased complications in both sexes.
Overall results did not demonstrate a sex-specific mortality effect of routine MCS. The subgroup interaction is hypothesis-generating rather than sufficient evidence for sex-based selection.
Study limitation: Women represented only 20% of participants, with wide confidence intervals limiting interpretation of sex-specific and exploratory subgroup estimates.
AI-generated from the published abstract with automated source checks. For research discovery; consult the original paper before applying findings.